BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 18, 2017
View Archived Issues
Mustang Bio, Fred Hutch enter CAR-T therapy license agreement
Read More
GSK receives positive opinion for self-injectable formulation of Benlysta for SLE
Read More
Santhera receives negative opinion from CHMP for its Type II extension application for Raxone in DMD
Read More
Preclinical data on LTC4 synthase inhibitor AZD-9898 reported
Read More
CHMP adopts positive opinion for Zubsolv as treatment of opioid dependence
Read More
Cenderitide safe in phase I study in patients with left ventricular assist device support
Read More
TG Therapeutics begins phase III studies of ublituximab in MS
Read More
Massachusetts General Hospital, Dana-Farber and Harvard patent antifungal compounds
Read More
Roche describes novel cathepsin S inhibitors
Read More
Intarcia Therapeutics reports topline results from study of switch from liraglutide to ITCA-650
Read More
Ontario Institute for Cancer Research discovers WDR5-MLL protein binding inhibitors
Read More
Shanghai Pharmaceuticals Holding identifies new EGFR/ERBB2 inhibitors
Read More
Ontruzant becomes the first trastuzumab biosimilar to receive a positive opinion from CHMP
Read More
Phoenix Molecular Designs synthesizes novel ribosomal s6 kinase inhibitors
Read More
ThromboGenics to regain Jetrea rights from Alcon
Read More
CHMP adopts negative opinion for masitinib marketing authorization in indolent systemic mastocytosis
Read More
EMA committee recommends approval of guselkumab for moderate to severe plaque psoriasis
Read More
Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo
Read More
RNA-targeted therapy with MRG-201 found safe and feasible in rats
Read More
FDA grants orphan drug designation to iclaprim for S. aureus lung infections in cystic fibrosis
Read More
CHMP issues positive opinion for Zejula
Read More
Vesicular stomatitis virus expressing reovirus FAST protein shows anticancer activity
Read More
Daratumumab given U.S. orphan status for light-chain amyloidosis
Read More
FDA grants priority review to Braeburn's NDA for CAM-2038 for opioid use disorder
Read More
Circulating miRNA signature could aid in determining prognosis in NSCLC
Read More
FDA approves Somatuline Depot for carcinoid syndrome
Read More